Abivax SA(ABVX.US)

Last Updated 19:00:00 ET
longbridge loading
Company Encyclopedia
View More
name
Abivax SA
ABVX.US
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn’s disease. The company was incorporated in 2013 and is headquartered in Paris, France.
1.850 T
ABVX.USMarket value -Rank by Market Cap -/-

Financial Score

21/05/2026 Update
D
BiotechnologyIndustry
Industry Ranking203/385
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-135.58%E
    • Profit Margin-7354.53%E
    • Gross Margin100.00%A
  • Growth ScoreD
    • Revenue YoY-60.62%E
    • Net Profit YoY-104.22%E
    • Total Assets YoY221.51%A
    • Net Assets YoY1166.55%A
  • Cash ScoreD
    • Cash Flow Margin47.94%C
    • OCF YoY-60.62%E
  • Operating ScoreE
    • Turnover0.01E
  • Debt ScoreA
    • Gearing Ratio22.10%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Arrowstreet Capital discloses net short position in Abivax shares

    PUBT·
    US
    ABVX
    +2.33%
    PUBT·
    US
    ABVX
    +2.33%

    Abivax says JPMorgan beneficial stake rises to 5.46% voting rights, 4,460,843 shares

    PUBT·
    US
    JPM
    -0.34%
    US
    ABVX
    +2.33%
    PUBT·
    US
    JPM
    -0.34%
    US
    ABVX
    +2.33%

    Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares

    Unusual Whales·
    US
    ABVX
    +2.33%
    US
    IBB
    -0.01%
    US
    VHT
    +0.07%
    Unusual Whales·
    US
    ABVX
    +2.33%
    US
    IBB
    -0.01%
    US
    VHT
    +0.07%

    Abivax Announces Repurchase of Royalty Certificates and Pricing of $45M (€38.5M) Offering of American Depositary Shares | ABVX Stock News

    StockTitan·
    US
    ABVX
    +2.33%
    StockTitan·
    US
    ABVX
    +2.33%

    Total Clarity Wealth Management Inc. Acquires Shares of 9,245 Abivax SA Sponsored ADR $ABVX

    Market Beat·
    US
    ABVX
    +2.33%
    US
    LABU
    -0.39%
    US
    VHT
    +0.07%
    Market Beat·
    US
    ABVX
    +2.33%
    US
    LABU
    -0.39%
    US
    VHT
    +0.07%
    © 2026 Longbridge｜Disclaimer